SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-127373
Filing Date
2023-04-28
Accepted
2023-04-28 16:46:57
Documents
8
Period of Report
2023-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A d467988ddef14a.htm DEF 14A 400055
2 GRAPHIC g467988dsp1.jpg GRAPHIC 2419
3 GRAPHIC g467988dsp1a.jpg GRAPHIC 1015
4 GRAPHIC g467988dsp1b.jpg GRAPHIC 907
5 GRAPHIC g467988dsp1c.jpg GRAPHIC 1244
6 GRAPHIC g467988dsp1d.jpg GRAPHIC 1220
7 GRAPHIC g467988dsp2.jpg GRAPHIC 1056
8 GRAPHIC g467988g88p02.jpg GRAPHIC 43317
  Complete submission text file 0001193125-23-127373.txt   472729
Mailing Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703
Business Address 18000 STUDEBAKER RD SUITE 800 CERRITOS CA 90703 562-735-3226
Oncology Institute, Inc. (Filer) CIK: 0001799191 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39248 | Film No.: 23867532
SIC: 8011 Services-Offices & Clinics of Doctors of Medicine